Early trials of the drug VIR-5500 showed it shrinking tumours in some patients ...

Men have been urged to contact their GP if they spot three warning signs when visiting the toilet. They could indicate an ...

A new drug for advanced prostate cancer has shown promise in early trials experts have said, with the medication shrinking tumors in some patients. Prostate cancer is the most common cancer among men ...

New prostate cancer drug showing ‘remarkable’ results during clinical trial - The new drug, known as VIR-5500, uses a ...

Doctors say active monitoring, hormone therapy and newer focal treatments are reshaping care decisions for men.

A DRUG that shrinks tumours in patients with untreatable prostate cancer has shown “remarkable” results, scientists have said. The treatment, called VIR-5500, harnesses the body’s ...

The average age of men who get diagnosed is 67.

Cancers Symposium, and the updates were full of hope for people with advanced prostate cancer. CURE highlights two studies ...

Men have been told to contact their GP if they notice three specific signs when using the bathroom as it could be an early ...

Docetaxel added to androgen deprivation therapy (ADT) was the most cost-effective first-line regimen for patients with homologous recombination repair–altered metastatic hormone-sensitive prostate ...

Men with prostate cancer are being denied NHS access to a treatment used by Lord Cameron, a senior doctor has revealed.

Former prime minister Rishi Sunak has told the BBC that a targeted prostate cancer screening programme is needed urgently, and would "save countless lives". Sunak is an ambassador for the Prostate ...